Atlas Trials

Triplet (FOLFOXIRI) vs. Doublet (FOLFOX or FOLFIRI) Regimen as a 1st Line Treatment in Metastatic Colorectal Carcinoma

Clinical trial NCT05316818 · COMPLETED

Trial details

NCT number
NCT05316818
Sponsor
Kasr El Aini Hospital
Status
COMPLETED
Phase
Phase 2
Study type
INTERVENTIONAL
Metastatic Colorectal Cancer
Start date
2018-01-16
Primary completion
2020-12-01
Enrollment
64

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.